Research ArticleSystemic Lupus Erythematosus
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
Serena Fasano, Luciana Pierro, Ilenia Pantano, Michele Iudici and Gabriele Valentini
The Journal of Rheumatology July 2017, 44 (7) 1032-1038; DOI: https://doi.org/10.3899/jrheum.161351
Serena Fasano
From the Department of Clinical and Experimental Medicine, Rheumatology Section, Second University of Naples, Naples,
Italy.
Luciana Pierro
Ilenia Pantano
Michele Iudici
Data supplements
Data Supplement
Files in this Data Supplement:
In this issue
The Journal of Rheumatology
Vol. 44, Issue 7
1 Jul 2017
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
Serena Fasano, Luciana Pierro, Ilenia Pantano, Michele Iudici, Gabriele Valentini
The Journal of Rheumatology Jul 2017, 44 (7) 1032-1038; DOI: 10.3899/jrheum.161351
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
Serena Fasano, Luciana Pierro, Ilenia Pantano, Michele Iudici, Gabriele Valentini
The Journal of Rheumatology Jul 2017, 44 (7) 1032-1038; DOI: 10.3899/jrheum.161351